Study of Maggot Therapy in Diabetic Foot Ulcers

NCT ID: NCT01681160

Last Updated: 2012-09-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

128 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was a Kind of clinical trial with equal randomization, that have been done from January 2009 to June 2011 in the AFZALIPOOR hospital endocrine ward in Kerman-Iran on 128 diabetic patient who had foot wounds.Replacement of conventional therapy by new methodes is one of the more important aims for health professional specially for nurses.One of this new treatment is maggot therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

DIABETIC FOOT ULCERS

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

MAGGOT THERAPY DIABETIC FOOT NURSING CARE DRESSING

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MAGGOT THERAPY & conventional therapy T

Maggot therapy,ADMINISTERED TWO TIMES AS A NEW METHODS OF DRESSING in experimental group.conventional therapy ,administered two times in control group

Group Type EXPERIMENTAL

procedure:maggot therapy

Intervention Type OTHER

each times in maggot therapy continued for three days.wound assessment was done before and after any intervention

conventional therapy

Intervention Type OTHER

patients receive ordinary treatment for diabetic foot

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

procedure:maggot therapy

each times in maggot therapy continued for three days.wound assessment was done before and after any intervention

Intervention Type OTHER

conventional therapy

patients receive ordinary treatment for diabetic foot

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

larval therapy mechanical debridement

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have a chronic illness more than 7 weeks.
* The age of the patients between 40- 90 years old.
* Not having capillary disease (Blockage of artery, Rinold).
* Not user of anticoagulants and corticosteroids drugs.
* Patients without history of allergy to drugs and foods.
* Having diabetic type 2

Exclusion Criteria

* patients who refer to critical clinical care unit
* patients who have amputation
Minimum Eligible Age

40 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kerman Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Forough Pouryazdanpanah Kermani

university instructor

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

86/116

Identifier Type: -

Identifier Source: org_study_id